Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Hosted content
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Hosted content
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
topic
Gut
CLINICAL
Gastroenterology
Liver disease
Email alerts
Liver disease
OP12 UK experience of treatment of chronic viral hepatitis C in children and adolescents: predictors of viral response and quality of life
M
Abdel-Hady
,
S
Bansal
,
S
Davison
,
M
Brown
,
S
Tizzard
,
S
Mulla
,
P
Davies
,
G
Mieli-Vergani
,
D
Kelly
Gut
Sep 2010,
59
(Suppl 2)
A5;
DOI:
10.1136/gut.2010.223362.12
OP11 Are simple non-invasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?
S
McPherson
,
Q
Anstee
,
E
Henderson
,
A
Burt
,
C
Day
Gut
Sep 2011,
60
(Suppl 2)
A54-A55;
DOI:
10.1136/gutjnl-2011-300857b.11
Quantitative magnetic resonance imaging (MRI) in the evaluation of the degree of steatosis, iron accumulation and fibrosis in chronic liver diseases (MRKER STUDY)
C L
Hoad
,
L
Marciani
,
P
Kaye
,
I N
Guha
,
C
Costigan
,
A
Austin
,
R C
Spiller
,
M W
James
,
P A
Gowland
,
S
Francis
,
G P
Aithal
Gut
Apr 2011,
60
(Suppl 1)
A55-A56;
DOI:
10.1136/gut.2011.239301.110
LY-6C intermediate and LY-6C
LO
intrahepatic macrophage subsets orchestrate resolution of hepatic fibrosis following chronic injury
P
Ramachandran
,
A
Pellicoro
,
M
Vernon
,
S N
Hartland
,
A
Ali
,
R L
Aucott
,
S J
Forbes
,
J P
Iredale
Gut
Apr 2011,
60
(Suppl 1)
A56;
DOI:
10.1136/gut.2011.239301.111
OP15 Discovery of new liver fibrosis markers in hepatitis C patients using proteomics
B
Gangadharan
,
M
Bapat
,
J
Rossa
,
R
Antrobus
,
D
Chittenden
,
B
Kampa
,
E
Barnes
,
R A
Dwek
,
N
Zitzmann
Gut
Sep 2011,
60
(Suppl 2)
A56;
DOI:
10.1136/gutjnl-2011-300857b.15
Depression in chronic hepatitis C is associated with low apolipoprotein e levels
D
Sheridan
,
M
Crossey
,
S Taylor
Robinson
,
S
Bridge
,
D
Felmlee
,
H
Thomas
,
G
Toms
,
D
Neely
,
M
Bassendine
Gut
Apr 2011,
60
(Suppl 1)
A58;
DOI:
10.1136/gut.2011.239301.115
Prevalence of abnormal liver function and response to lifestyle interventions in newly diagnosed type 2 diabetes: preliminary results of a UK randomised controlled study
R
Parker
,
N
Guthrie
,
N
Patel
,
W
Woltersdorf
,
R
Andrews
,
C
Dayan
,
C A
McCune
,
Early ACTID
Gut
Apr 2011,
60
(Suppl 1)
A59;
DOI:
10.1136/gut.2011.239301.117
OP14 Measurement of low density apolipoprotein B associated hepatitis C virus lipoviral particles in genotype 1 infection is more clinically relevant than total viral load
D
Sheridan
,
S
Bridge
,
D A
Sheridan
,
D
Felmlee
,
H
Thomas
,
S
Taylor-Robinson
,
R
Dermot
,
G
Neely
,
G L
Toms
,
M F
Bassendine
Gut
Sep 2010,
59
(Suppl 2)
A6;
DOI:
10.1136/gut.2010.223362.14
OP18 Abnormal liver histology in patients taking methotrexate correlates poorly with dosage or duration of therapy and reflects established risk factors for steatohepatitis
R
Aspinall
,
A
Joshi
,
A
Godkin
,
K
Roberts
,
G
Williams
Gut
Sep 2010,
59
(Suppl 2)
A7-A8;
DOI:
10.1136/gut.2010.223362.18
P15 Multiple defects of the immunoregulatory system contribute to the development of autoimmune hepatitis
P
Wang
,
M S
Longhi
,
G
Mieli-Vergani
,
D
Vergani
,
Y
Ma
Gut
Sep 2011,
60
(Suppl 2)
A7;
DOI:
10.1136/gutjnl-2011-300857a.15
Pages
« first
‹ previous
…
76
77
78
79
80
81
82
83
84
next ›
last »
CLINICAL
Evidence based practice
Guidelines
(34)
Gastroenterology
Drugs: gastrointestinal system
(216)
Endoscopy
(1096)
GI bleeding
Angiodysplasia
(16)
Neoplasms
Ulcer
(495)
Varices
Infection
Campylobacter, Salmonella, Shigella, Escherichia coli
(258)
Clostridium difficile
(74)
Gastroenteritis
(59)
Giardiasis
(22)
Helicobacter pylori
(232)
Parastic worms
(2)
Inflammatory bowel disease
Crohn's disease
(1068)
Ulcerative colitis
(1177)
Liver disease
Alcoholic liver disease
(134)
Cirrhosis
(383)
Hepatitis B
(107)
Hepatitis C
(172)
Hepatitis other
(169)
Nonalcoholic steatosis
(158)
Neurogastroenterology
Chronic intestinal pseudo-obstruction
(34)
Constipation
(206)
Diarrhoea
(689)
Disordered defaecation
Disordered visceral sensation
Dyspepsia
(322)
Gastric emptying disorders
(46)
Irritable bowel syndrome
(359)
Oesophageal dysmotility
(7)
Oesophagus
Gastro-oesophageal reflux
(374)
Pancreas and biliary tract
(2089)
Pancreatitis
(574)
Small intestine
Coeliac disease
(561)
Gastrointestinal hormones
(868)
Malabsorption
(24)
Stomach and duodenum
(1734)
Infectious diseases
Oncology
Cancer: small intestine
(208)
Colon cancer
(1781)
Gastric cancer
Hepatic cancer
(566)
Oesophageal cancer
(401)
Pancreatic cancer
(776)
Special collections
Colorectal Cancer Screening
(8)
Editor's choice
(125)
Guidelines, Recommendations and Consensus Statements
Gut Education
(89)
GUT Recent advances in basic science
(145)
GUT Recent advances in clinical practice
(164)
GUT Snapshot
(406)
IBD issue
(6)
Open access
(695)
Press releases
(71)